Radioimmunotherapy with 90Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network - Publication - MOST Wiedzy

Search

Radioimmunotherapy with 90Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

Abstract

Citations

  • 8

    CrossRef

  • 6

    Web of Science

  • 5

    Scopus

Authors

  • Photo of  K Hohloch

    K Hohloch

  • Photo of  P Zinzani

    P Zinzani

  • Photo of  W Linkesch

    W Linkesch

  • Photo of  W Jurczak

    W Jurczak

  • Photo of  A Deptala

    A Deptala

  • Photo of  M Lorsbach

    M Lorsbach

  • Photo of  C Windemuth-Kiesselbach

    C Windemuth-Kiesselbach

  • Photo of  G Wulf

    G Wulf

  • Photo of  L Truemper

    L Truemper

Full text

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
BONE MARROW TRANSPLANTATION no. 46, edition 6, pages 901 - 903,
ISSN: 0268-3369
ISSN:
0268-3369
Publication year:
2011
DOI:
Digital Object Identifier (open in new tab) 10.1038/bmt.2010.202
Verified by:
No verification

seen 9 times

Meta Tags